Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: ENOV

Enovis Corporation

Healthcare | Medical - Devices

No licensed closing price on file for ENOV. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-19.30

Enovis Corporation (NYSE: ENOV) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 04:44 UTC.

What Enovis Corporation does

Enovis Corporation is a medical technology company that manufactures and distributes medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through two segments: Prevention Recovery, which includes orthopedic bracing, hot and cold therapy, bone growth stimulators, and pain management devices; and Reconstructive, which focuses on surgical implants and instrumentation for joint replacement and limb reconstruction.

Summarized from Enovis Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-19.30
Debt/equity0.87

Revenue, margins & earnings

FY2021 Revenue: $1.43B — margin split not shown (non-operating gains)$1.43BFY2021FY2022: net loss $13M on revenue $1.56B$1.56BFY2022FY2023: net loss $33M on revenue $1.71B$1.71BFY2023FY2024: net loss $825M on revenue $2.11B$2.11BFY2024FY2025: net loss $1.18B on revenue $2.25B$2.25BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-01
  • 2026-10-01DirectorAward958—
  • 2026-09-08Chief Administrative OfficerPurchase2,660$50.0K
  • 2026-09-04Chief Executive OfficerPurchase13,035$249.6K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Enovis Corporation do?

Enovis Corporation is a medical technology company that manufactures and distributes medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy.

When did ENOV last file with the SEC?

Enovis Corporation's most recent SEC filing on record is a 8-K filed 2026-05-19. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 04:44 UTC. This page is also available as JSON at /api/data?ticker=ENOV and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ENOV and 5,000+ tickers.

Create a free account — keep ENOV
For your agent
GET /api/data?ticker=ENOV

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt